Location & dates EMBL Heidelberg, Germany 4 - 6 Nov 2019 Register Now
Deadlines Registration - 23 Sep 2019 Abstract - 26 Aug 2019

Programme

Got something to say? Tweet it! #EMBLCanGen

Day 1 - Monday 4 November 2019
TimeSpeaker
11:00-13:00 Arrival / Registration
with light refreshments
13:00-13:15 Opening remarks
13:15-16:45

Session 1: Cancer genetics and mutation

13:15-13:45

Somatic mutation and clonal expansions in healthy tissues
Inigo Martincorena, Wellcome Trust Sanger Institute, UK

13:45-14:00

Selected talk

14:00-14:15

Selected talk

14:15-14:45

Full-length transcript isoforms associated with SF3B1 mutation in chronic lymphocytic leukemia
Angela Brooks, University of California, Santa Cruz, USA

14:45-15:15

Coffee break

15:15-15:45

Synthetic Lethal candidates search using genomic and methylation features
Francesca Demichelis, University of Trento, Italy

15:45-16:00

Selected talk

16:00-16:15

Selected talk

16:15-16:45

Matthew L. Meyerson, Dana-Farber Cancer Institute, USA

16:45-17:15

Coffee break & Meet the speakers

17:15-18:15

Keynote: Stefan M. Pfister, Hopp Children's Cancer Center Heidelberg (KiTZ), Germany

18:15-18:30

Apéritif in the ATC Foyer

18:30-20:00 Dinner in the EMBL Canteen
20:00-21:30 Welcome reception and digital poster presentations in ATC Foyer with live music
Day 2 - Tuesday 5 November 2019
TimeSpeaker
09:00-12:00 Session 2: Cancer & microenvironment: immunogenomics & single cells
09:00-09:30

Building personalized cancer vaccines
Catherine J. Wu, Dana-Farber Cancer Institute, USA

09:30-09:45

Selected talk

09:45-10:00

Selected talk

10:00-10:30

Tumor Genomic Profiling to Identify Therapeutic Biomarkers and Guide Clinical Care
Michael F. Berger, Memorial Sloan Kettering Cancer Center, USA

10:30-11:00

Coffee break

11:00-11:30

Somatic mutations in normal tissues
Peter Campbell, Wellcome Trust Sanger Institute, UK

11:30-11:45 Selected talk
11:45-12:00

Selected talk

12:00-13:30

Lunch

13:30-15:00

Poster Session I (odd numbers)

15:00-17:45

Session 3: Cancer genome and epigenome

15:00-15:30

Julie George, University of Cologne, Germany

15:30-15:45

Selected talk

15:45-16:00

Selected talk

16:00-16:30

Elías Campo, Hospital Clinic of the University of Barcelona, Spain

16:30-17:00 Coffee break & Meet the speakers
17:00-17:30 Sean Grimmond, The University of Melbourne, Australia
17:30-17:45 Selected talk
17:45-18:45 Keynote: 
Partnering with patients to accelerate cancer genomics and precision medicine
Nikhil Wagle, Dana-Farber Cancer Institute, USA
18:45-19:00 Apéritif in the ATC Foyer
19:00-21:00

Conference Dinner in the EMBL Canteen

21:00-00:00 Conference Party in the ATC Foyer
Day 3 - Wednesday 6 November 2019
TimeSpeaker
09:00-12:00 Session 4: Drivers of cancer and genome-wide functional screens
09:00-09:30 Accelerating prediction of tumor vulnerabilities using precision functional genomics
Jesse S. Boehm, Broad Institute, USA
09:30-09:45

Selected talk

09:45-10:00

Selected talk

10:00-10:30

Núria López-Bigas, ICREA, Institute for Research in Biomedicine, Spain

10:30-11:00 Coffee break
11:00-11:30

Jan Korbel, EMBL Heidelberg, Germany

11:30-11:45

Selected talk

11:45-12:00

Selected talk

12:00-13:30 Lunch
13:30-15:00 Poster Session II (even numbers)
15:00-17:45

Session 5: Cancer genome medicine

15:00-15:30

Mathew Garnett, Wellcome Trust Sanger Institute, UK

15:30-15:45

Selected talk

15:45-16:00

Selected talk

16:00-16:15

Selected tallk

16:15-16:45

Coffee break & Meet the speakers

16:45-17:15

Elli Papaemmanuil, Memorial Sloan Kettering Cancer Center, USA

17:15-17:45

Molecular minimal residual disease detection in AML and clonal hematopoiesis
Peter J.M. Valk, Erasmus University Medical Center, The Netherlands

17:45-18:00 Closing remarks and Poster prize